AI assistant could spot hidden liver and pancreas cancers earlier

NCT ID NCT07716670

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study is developing and testing an artificial intelligence (AI) system designed to help doctors diagnose diseases of the liver, bile ducts, and pancreas. The AI acts like a smart assistant that talks with patients to collect their symptoms, risk factors, and medical history, then creates a structured summary for the doctor. The trial involves 400 adults aged 18 to 75 who have or are suspected of having these conditions. The goal is to see whether the AI-generated summaries improve the completeness and accuracy of the information doctors have when making a diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
an AI-based multi-agent pre-consultation system that collects symptoms and generates diagnostic summaries
What this could lead to
If successful, this AI tool could help doctors catch liver, bile duct, and pancreas diseases earlier, reducing misdiagnosis in busy clinics.
What could go wrong
This is an early-stage study focused on developing and testing the AI system, not on patient outcomes. The AI may not improve diagnosis in real-world settings and could introduce errors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTIFICIAL INTELLIGENCE (AI) IN DIAGNOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.